Alpha Tau Medical Ltd. (DRTS) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DRTS Revenue Growth
DRTS Revenue Analysis (2019–2025)
As of May 8, 2026, Alpha Tau Medical Ltd. (DRTS) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, DRTS's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), IART (+1.2% YoY), and ARAY (-7.9% YoY). Compare DRTS vs NVCR →
DRTS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DRTSCurrent | $0 | - | - | - | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 IART | $1.6B | +1.2% | +3.6% | 4.2% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 MRKR | $4M | -46.2% | +50.0% | -350.7% | |
 RLAY | $15M | +39.0% | -28.6% | -1971.6% |
DRTS Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-1,232,000 | - | $-42,288,000 | - |
| 2024 | $0 | - | $-1,102,000 | - | $-36,042,000 | - |
| 2023 | $0 | - | $-1,074,000 | - | $35.7M | - |
| 2022 | $0 | - | $-979,000 | - | $-32,136,000 | - |
| 2021 | $0 | - | $-776,000 | - | $-13,790,000 | - |
| 2020 | $0 | - | $-86,000 | - | $-9,244,000 | - |
| 2019 | $0 | - | $0 | - | $-8,010,000 | - |
See DRTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DRTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DRTS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDRTS — Frequently Asked Questions
Quick answers to the most common questions about buying DRTS stock.
Is DRTS's revenue growth accelerating or slowing?
DRTS TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is DRTS's long-term revenue growth rate?
Alpha Tau Medical Ltd.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is DRTS's revenue distributed by segment?
DRTS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.